We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNOA icon
5601
Sonoma Pharmaceuticals
SNOA
$6.32M
$2K ﹤0.01%
26
-42
-62% -$2.69K
SNTI icon
5602
Senti Biosciences Holdings
SNTI
$11M
$2K ﹤0.01%
123
+52
+73% +$4.18K
SOPH icon
5603
SOPHiA GENETICS
SOPH
$647M
$2K ﹤0.01%
+528
New +$2.68K
SPLB icon
5604
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.18B
$2K ﹤0.01%
89
-20
-18% -$501
TOVX icon
5605
Theriva Biologics
TOVX
$10.7M
$2K ﹤0.01%
44
+5
+13% +$286
TUGN icon
5606
STF Tactical Growth & Income ETF
TUGN
$83.9M
$2K ﹤0.01%
+100
New +$2.43K
TXMD icon
5607
TherapeuticsMD
TXMD
$24.3M
$2K ﹤0.01%
200
-603
-75% -$5.76K
UAMY icon
5608
United States Antimony
UAMY
$974M
$2K ﹤0.01%
+5,484
New +$2.38K
UAVS icon
5609
AgEagle Aerial Systems
UAVS
$61.5M
$2K ﹤0.01%
4
-10
-71% -$8.31K
USA icon
5610
Liberty All-Star Equity Fund
USA
$1.87B
$2K ﹤0.01%
+293
New +$2.03K
USAC icon
5611
USA Compression Partners
USAC
$3.74B
$2K ﹤0.01%
125
-953
-88% -$17.1K
USIO icon
5612
Usio Inc
USIO
$61.3M
$2K ﹤0.01%
798
-1,390
-64% -$3.68K
UUU icon
5613
Universal Safety Products Inc
UUU
$10.6M
$2K ﹤0.01%
542
+526
+3,288% +$1.79K
VLN icon
5614
Valens Semiconductor
VLN
$182M
$2K ﹤0.01%
651
-116
-15% -$422
WWR icon
5615
Westwater Resources
WWR
$78.6M
$2K ﹤0.01%
2,087
-1,890
-48% -$2.46K
WYY icon
5616
WidePoint Corp
WYY
$111M
$2K ﹤0.01%
793
– –
XHB icon
5617
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
$2K ﹤0.01%
35
-23,227
-100% -$1.4M
YYY icon
5618
Amplify CEF High Income ETF
YYY
$743M
$2K ﹤0.01%
139
+10
+8% +$137
ZH
5619
Zhihu
ZH
$284M
$2K ﹤0.01%
154
-497
-76% -$5.34K
CERO
5620
DELISTED
CERo Therapeutics
CERO
– –
0
– –
SHRY icon
5621
First Trust Exchange-Traded Fund VI First Trust Bloomberg Shareholder Yield ETF
SHRY
$16.5M
$2K ﹤0.01%
62
– –
NTRP icon
5622
NextTrip
NTRP
$22.5M
$2K ﹤0.01%
+85
New +$2.39K
LENZ
5623
LENZ Therapeutics
LENZ
$167M
$2K ﹤0.01%
102
-295
-74% -$6.58K
AIOT
5624
PowerFleet Inc
AIOT
$395M
$2K ﹤0.01%
1,045
-369
-26% -$937
QCLS
5625
Q/C Technologies Inc
QCLS
$22.5M
– –
0
– –
223 224
225
226 227

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.